Essex Investment Management CO LLC Vertex Pharmaceuticals Inc Transaction History

Essex Investment Management CO LLC

$536 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $678,619 - $774,147	-2,396 Reduced 17.97%	10,939 $3.45 Million
Q4 2022 Feb 02, 2023	SELL	$285.76 - $321.48 $11,716 - $13,180	-41 Reduced 0.31%	13,335 $3.85 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $230,564 - $257,256	-842 Reduced 5.92%	13,376 $3.87 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $156,483 - $194,838	-666 Reduced 4.47%	14,218 $4.01 Million
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $151,894 - $179,025	-686 Reduced 4.41%	14,884 $3.88 Million
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $187,630 - $236,857	-1,060 Reduced 6.37%	15,570 $3.42 Million
Q3 2021 Nov 09, 2021	SELL	$181.39 - $202.99 $1.26 Million - $1.41 Million	-6,933 Reduced 29.42%	16,630 $3.02 Million
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $341,794 - $403,065	-1,823 Reduced 7.18%	23,563 $4.75 Million
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $221,097 - $257,719	-1,068 Reduced 4.04%	25,386 $5.46 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $2.6 Million - $3.46 Million	-12,550 Reduced 32.18%	26,454 $6.25 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $165,661 - $196,408	-648 Reduced 1.63%	39,004 $10.6 Million
Q2 2020 Aug 04, 2020	SELL	$225.48 - $295.8 $1.96 Million - $2.57 Million	-8,700 Reduced 17.99%	39,652 $11.5 Million
Q1 2020 May 04, 2020	SELL	$199.77 - $247.81 $635,867 - $788,779	-3,183 Reduced 6.18%	48,352 $11.5 Million
Q4 2019 Feb 10, 2020	SELL	$166.71 - $223.91 $24,006 - $32,243	-144 Reduced 0.28%	51,535 $11.3 Million
Q3 2019 Oct 22, 2019	BUY	$166.23 - $187.09 $1.57 Million - $1.76 Million	9,433 Added 22.33%	51,679 $8.76 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $1.1 Million - $1.31 Million	-6,704 Reduced 13.7%	42,246 $7.77 Million
Q4 2018 Feb 06, 2019	SELL	$151.91 - $192.21 $1.92 Million - $2.42 Million	-12,607 Reduced 20.48%	48,950 $8.11 Million
Q3 2018 Oct 16, 2018	SELL	$167.73 - $192.74 $534,723 - $614,455	-3,188 Reduced 4.92%	61,557 $11.9 Million
Q2 2018 Jul 17, 2018	BUY	$145.72 - $169.96 $982,881 - $1.15 Million	6,745 Added 11.63%	64,745 $11 Million
Q1 2018 Apr 26, 2018	BUY	$151.6 - $177.13 $20,617 - $24,089	136 Added 0.24%	58,000 $9.45 Million
Q4 2017 Feb 05, 2018	BUY	$137.28 - $155.55 $403,054 - $456,694	2,936 Added 5.35%	57,864 $8.67 Million
Q3 2017 Oct 30, 2017	BUY	$148.13 - $162.24 $8.14 Million - $8.91 Million	54,928	54,928 $8.35 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.61 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.33 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.06 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Account